IP Library Assignment 026999/0545
Patent Assignment
Reel/Frame 026999/0545

Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 026825 Frame 0898. Assignor(S) Hereby Confirms the Assignee Name Is Resverlogix Corp..

Recorded: 2011-09-30 Pages: 4
Assignor
HANSEN, HENRIK C.
Executed: 2011-08-10
Assignee
RESVERLOGIX CORP.
279 MIDPARK WAY SE, SUITE 202, CALGARY, AB, T2X 1M2, CANADA
Covered Property (1)
Compounds for the Prevention and Treatment of Cardiovascular Disease
Patent: 8,952,021 →
Application: 13/143,757 →
Publication: US 2011/0294807
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 30, 2011
From: HANSEN, HENRIK C.
To: RESVERLOGIX CORPORATION
Reel/Frame 026825/0898 →
Security Interest Jun 14, 2018
From: RESVERLOGIX CORP.
To: THIRD EYE CAPITAL CORPORATION
Reel/Frame 046090/0103 →
Security Interest Sep 27, 2019
From: RESVERLOGIX CORP.
To: VISION LEADER LIMITED
Reel/Frame 050518/0714 →
Release of Security Interest Oct 17, 2019
From: THIRD EYE CAPITAL CORPORATION
To: RESVERLOGIX CORP.
Reel/Frame 050763/0175 →
Release of Security Interest Jan 12, 2021
From: VISION LEADER LIMITED
To: RESVERLOGIX CORP.
Reel/Frame 054888/0506 →